|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Zantac (Ranitidine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (100)
Cases resulting in a serious event (95)
Cases resulting in death (7)
Cases resulting in life threatening events (25)
Cases resulting in hospitalization (49)
Cases resulting in disability (2)
Cases resulting in other serious reactions (34)
Below is a sample of reports where side effects / adverse reactions may be related to Zantac (Ranitidine). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-10-30
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Respiratory Failure, Lung Abscess
Adverse event resulted in: death
Suspect drug(s):
Finibax
Finibax
Indication: Lung Abscess
Norvasc
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Itraconazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Zantac
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Ferromia
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Erythrocin
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Biofermin R
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sucralfate
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Slow-K
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Mucosta
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Juzen-Taiho-TO
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Cravit
Adverse event in receiving Zantac (Ranitidine)
Reported by a pharmacist from United Kingdom on 2007-10-25
Patient:
Adverse reactions / side effects: Macular Degeneration
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-10-19
Patient: male
Adverse reactions / side effects: Interstitial Lung Disease, Lung Abscess
Adverse event resulted in: death, life threatening event
Suspect drug(s):
Finibax
Finibax
Indication: Lung Abscess
Norvasc
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Itraconazole
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Zantac
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Ferromia
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Erythrocin Lactobionate
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Biofermin R
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Sucralfate
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Slow-K
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Mucosta
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Juzen-Taiho-TO
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Levofloxacin
Adverse event in 2 month old male receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from United States on 2007-10-17
Patient: 2 month old male, weighing 5.4 kg (11.9 pounds)
Adverse reactions / side effects: Drug Exposure VIA Breast Milk, Erythema Multiforme
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in 77 year old male receiving Zantac (Ranitidine)
Reported by a pharmacist from Japan on 2007-10-05
Patient: 77 year old male
Adverse reactions / side effects: Agranulocytosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Aspirin
Dosage: total daily dose: 100 mg unit dose: 100 mg
Administration route: Oral
End date: 2007-06-11
Zantac
Dosage: total daily dose: 150 mg unit dose: 150 mg
Administration route: Oral
End date: 2007-06-11
Lipitor
Dosage: total daily dose: 10 mg unit dose: 10 mg
Administration route: Oral
End date: 2007-06-11
Tenormin
Dosage: total daily dose: 50 mg unit dose: 50 mg
Administration route: Oral
End date: 2007-06-11
Pletal
Administration route: Oral
End date: 2007-06-11
Bepricor
Administration route: Oral
End date: 2007-06-11
Sigmart
Administration route: Oral
End date: 2007-06-11
Lendormin
Administration route: Oral
Indication: Insomnia
End date: 2007-06-11
Warfarin Potassium
Administration route: Oral
End date: 2007-06-11
Other drugs received by patient: Lasix; Mucosolvan
Adverse event in 65 year old female receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-10-05
Patient: 65 year old female
Adverse reactions / side effects: Cardio-Respiratory Arrest, Vomiting, Cyanosis, Angiopathy, Pallor, Cough, Shock
Adverse event resulted in: life threatening event
Suspect drug(s):
Zantac
Dosage: 50mg per day
Indication: Fallopian Tube Cancer
Start date: 2006-12-07
End date: 2007-04-05
Kytril
Dosage: 3mg per day
Indication: Fallopian Tube Cancer
Start date: 2006-12-07
End date: 2007-04-05
Other drugs received by patient: Decadron; Vena; Sodium Chloride 0.9%; Veen-D; Bosmin
Adverse event in 66 year old female receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-10-02
Patient: 66 year old female, weighing 58.0 kg (127.6 pounds)
Adverse reactions / side effects: Aplastic Anaemia, Bone Marrow Failure
Adverse event resulted in: hospitalization
Suspect drug(s):
Prograf
Dosage: 3 mg, /d, oral
Administration route: Oral
Indication: Interstitial Lung Disease
Start date: 2006-08-01
End date: 2007-07-13
Zantac
End date: 2007-07-13
Other drugs received by patient: Predonide (Prednisolone); Baktar (Sulfamethoxazole, Trimethoprim); Bonalon (Alendronic Acid); Panaldine (Ticlopidine Hydrochloride); Crestor
Adverse event in 43 year old male receiving Zantac (Ranitidine)
Reported by a pharmacist from United States on 2007-07-24
Patient: 43 year old male
Adverse reactions / side effects: Liver Function Test Abnormal
Adverse event resulted in: hospitalization
Suspect drug(s):
Zantac (Ranitidine)
Other drugs received by patient: Multi-Vitamin; Zofran; Promethazine; Insulin; Tylenol (Caplet); Risperidone; Oxycodone HCL; Colace; Heparin; Morphine
Adverse event in 45 year old male receiving Zantac (Ranitidine)
Reported by a pharmacist from United Kingdom on 2007-07-19
Patient: 45 year old male
Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Rhabdomyolysis
Adverse event resulted in: hospitalization
Suspect drug(s):
Floxapen
Indication: Drug USE FOR Unknown Indication
Zantac
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Hydrocortisone; Ciprofloxacin
Adverse event in 59 year old female receiving Zantac (Ranitidine)
Reported by a individual with unspecified qualification from United States on 2007-07-13
Patient: 59 year old female
Adverse reactions / side effects: Intraocular Pressure Increased, Gastric Ulcer
Suspect drug(s):
Boniva
Dosage: 150 mg oral
Administration route: Oral
Indication: Osteoporosis Postmenopausal
Start date: 2006-08-15
End date: 2007-02-15
Zantac
Other drugs received by patient: Xanax; Tums (Calcium Carbonate); Protonix
Adverse event in 64 year old female receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-07-12
Patient: 64 year old female
Adverse reactions / side effects: C-Reactive Protein Increased, Pancytopenia, Pyrexia
Adverse event resulted in: hospitalization
Suspect drug(s):
Zantac (Ranitidine)
Other drugs received by patient: Omepral; Ciprofloxacin; Prodif; Vancomycin HCL; Vancomycin HCL; Maxipime; Gran; Predonine; Predonine
Adverse event in receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from Canada on 2007-07-10
Patient:
Adverse reactions / side effects: Intentional Overdose
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in 12 year old female receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from Canada on 2007-07-10
Patient: 12 year old female
Adverse reactions / side effects: Personality Change, Affect Lability, Medication Error, Self-Injurious Ideation
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in 90 year old male receiving Zantac (Ranitidine)
Reported by a individual with unspecified qualification from France on 2007-07-06
Patient: 90 year old male
Adverse reactions / side effects: Thrombocytopenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Keppra
Dosage: 1000 mg /d po
Administration route: Oral
End date: 2006-01-30
Zantac
Dosage: 150 mg /d po
Administration route: Oral
End date: 2006-01-30
Allopurinol
Dosage: 200 mg/d po
Administration route: Oral
End date: 2006-01-30
Paroxetine HCL
Dosage: 20 mg /d po
Administration route: Oral
End date: 2006-02-03
Other drugs received by patient: Irbesartan; Synacthene; Depakene; Zolpidem Tartrate
Adverse event in 76 year old male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-07-06
Patient: 76 year old male
Adverse reactions / side effects: Neutrophil Count Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Aspirin
Dosage: daily dose:100mg-freq:day
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Zantac
Dosage: daily dose:150mg-freq:day
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Tenormin
Dosage: daily dose:50mg-freq:day
Administration route: Oral
Pletal
Administration route: Oral
Bepricor
Dosage: daily dose:100mg-freq:day
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Sigmart
Dosage: daily dose:15mg-freq:day
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Lendormin
Dosage: daily dose:.25mg-freq:day
Administration route: Oral
Warfarin Sodium
Dosage: daily dose:.5mg-freq:day
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Adverse event in 20 year old female receiving Zantac (Ranitidine)
Reported by a health professional (non-physician/pharmacist) from France on 2007-07-02
Patient: 20 year old female
Adverse reactions / side effects: Neutropenia, Normochromic Normocytic Anaemia
Adverse event resulted in: hospitalization
Suspect drug(s):
Effexor
Dosage: unknown
Administration route: Oral
End date: 2007-02-15
Rubozinc
Dosage: unknown
Administration route: Oral
Start date: 2007-02-23
End date: 2007-02-01
Zantac
Dosage: unknown
Administration route: Oral
Start date: 2007-01-01
End date: 2007-02-01
Other drugs received by patient: Atarax; Calcium Carbonate; Hept-A-MYL; Phocytan; Vitamin B1 and B6; Diffu K; Imodium; Tiorfan; Colecalciferol
Adverse event in 2 month old female receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from United States on 2007-07-02
Patient: 2 month old female
Adverse reactions / side effects: Overdose, Developmental Delay, Convulsion
Adverse event resulted in: hospitalization
Suspect drug(s):
Zantac (Ranitidine)
Other drugs received by patient: NO Concurrent Medication
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-07-02
Patient: male
Adverse reactions / side effects: Neutrophil Count Decreased
Suspect drug(s):
Lipitor
Dosage: daily dose:10mg
Administration route: Oral
Atenolol
Dosage: daily dose:50mg
Administration route: Oral
Indication: Cardiac Failure
Aspirin
Dosage: daily dose:100mg
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Bepricor
Dosage: daily dose:100mg
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Pletal
Administration route: Oral
Sigmart
Dosage: daily dose:15mg
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Warfarin Sodium
Dosage: daily dose:.5mg
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Zantac
Dosage: daily dose:150mg
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Lendormin
Dosage: daily dose:.25mg-freq:frequency: prn
Administration route: Oral
Other drugs received by patient: Furosemide; Ambroxol Hydrochloride
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-06-28
Patient: male
Adverse reactions / side effects: Dyspnoea, Pulmonary Oedema, Myelodysplastic Syndrome, Pleural Effusion, Neutrophil Count Decreased
Suspect drug(s):
Tenormin
Administration route: Oral
Indication: Cardiac Failure
End date: 2007-06-10
Aspirin
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Bepricor
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Lendormin
Administration route: Oral
End date: 2007-06-10
Lipitor
Administration route: Oral
End date: 2007-06-10
Pletal
Administration route: Oral
Sigmart
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Warfarin Potassium
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Zantac
Administration route: Oral
Start date: 2007-04-27
End date: 2007-06-10
Other drugs received by patient: Furosemide; Ambroxol Hydrochloride
Adverse event in male receiving Zantac (Ranitidine)
Reported by a physician from United States on 2007-06-28
Patient: male
Adverse reactions / side effects: Osteonecrosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Enbrel
Indication: Rheumatoid Arthritis
Start date: 2004-01-01
Methotrexate
Start date: 2006-10-01
Mobic
Administration route: Oral
Start date: 2006-10-01
Vicodin ES
Start date: 2006-10-01
Zantac
Start date: 2006-10-01
Lorazepam
Start date: 2006-10-01
Adverse event in 77 year old female receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-06-26
Patient: 77 year old female, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Rhabdomyolysis, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Alanine Aminotransferase Increased, Hypoaesthesia, Long QT Syndrome, Dysstasia, Convulsions Local, C-Reactive Protein Increased, Aspartate Aminotransferase Increased
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Zantac (Ranitidine)
Other drugs received by patient: Cyanocobalamin; Vitamedin; Mucosta
Adverse event in 55 year old male receiving Zantac (Ranitidine)
Reported by a physician from Japan on 2007-06-22
Patient: 55 year old male
Adverse reactions / side effects: Blood Bilirubin Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in 27 year old female receiving Zantac (Ranitidine)
Reported by a physician from Mexico on 2007-06-22
Patient: 27 year old female
Adverse reactions / side effects: Dyspnoea, Pruritus, Urticaria, Dizziness, Pharmaceutical Product Complaint
Suspect drug(s):
Zantac (Ranitidine)
Adverse event in 77 year old male receiving Zantac (Ranitidine)
Reported by a pharmacist from Japan on 2007-06-21
Patient: 77 year old male
Adverse reactions / side effects: Neutropenia
Adverse event resulted in: hospitalization
Suspect drug(s):
Aspirin
Dosage: total daily dose: 100 mg unit dose: 100 mg
Administration route: Oral
End date: 2007-06-11
Zantac
Dosage: total daily dose: 150 mg unit dose: 150 mg
Administration route: Oral
End date: 2007-06-11
Lipitor
Dosage: total daily dose: 10 mg unit dose: 10 mg
Administration route: Oral
End date: 2007-06-11
Tenormin
Dosage: total daily dose: 50 mg unit dose: 50 mg
Administration route: Oral
End date: 2007-06-11
Pletal
Administration route: Oral
End date: 2007-06-11
Bepricor
Administration route: Oral
End date: 2007-06-11
Sigmart
Administration route: Oral
End date: 2007-06-11
Lendormin
Administration route: Oral
Indication: Insomnia
End date: 2007-06-11
Warfarin Potassium
Administration route: Oral
End date: 2007-06-11
Other drugs received by patient: Lasix; Mucosolvan
Adverse event in 58 year old male receiving Zantac (Ranitidine)
Reported by a consumer/non-health professional from France on 2007-06-20
Patient: 58 year old male, weighing 78.0 kg (171.6 pounds)
Adverse reactions / side effects: Bone Marrow Failure
Adverse event resulted in: life threatening event
Suspect drug(s):
Zantac
Start date: 2006-09-15
End date: 2006-09-15
Trandate
Start date: 2006-09-07
End date: 2006-09-17
Ciflox
Dosage: 750mg per day
Indication: Prostatitis
Start date: 2006-08-25
End date: 2006-09-14
Omeprazole
Start date: 2006-07-05
End date: 2006-09-12
Vfend
Start date: 2006-07-27
End date: 2006-09-11
Valganciclovir HCL
Start date: 2006-08-16
End date: 2006-09-11
|
